---
title: "CMB.TECH NV Stock 12‑Month Price Target Raised to $17.01, Implies 13% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286902384.md"
description: "CMB.TECH NV's average stock price target has increased from $16.81 to $17.01, suggesting a potential upside of 13%. The consensus rating remains 'Buy' from 12 analysts, with 9 Buys, 3 Holds, and no Sells. Price forecasts range from $12.82 to $19.03 per share."
datetime: "2026-05-19T11:20:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286902384.md)
  - [en](https://longbridge.com/en/news/286902384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286902384.md)
---

# CMB.TECH NV Stock 12‑Month Price Target Raised to $17.01, Implies 13% Upside

-   According to estimates from 12 analysts, CMB.TECH NV stock's average price target has risen from $16.81 to $17.01, with forecasts ranging from $12.82 to $19.03 per share
-   Based on the May 18 closing price, the updated target implies approximately 13% potential upside
-   Consensus rating remains at “Buy” across 12 covering analysts, with 9 Buys, 3 Holds and 0 Sells

Explore more price target data and ratings for CMB.TECH NV on the , and track all previous and future analyst recommendations for CMB.TECH NV in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [CMBT.US](https://longbridge.com/en/quote/CMBT.US.md)

## Related News & Research

- [CMB.TECH Posts Record Q1 2026 Profit and Expands Contract Backlog](https://longbridge.com/en/news/286974665.md)
- [Tanker rates soar, but Hormuz opening may move them either way, CMB.Tech boss says](https://longbridge.com/en/news/286906103.md)
- [Best Buy leak hints GTA VI pre-orders may start May 18](https://longbridge.com/en/news/286472709.md)
- [The S&P 500 Just Completed Its 7th Straight Up Week. History Says It's Still Time to Buy.](https://longbridge.com/en/news/287006210.md)
- [Assessing BioMarin Pharmaceutical (BMRN) Valuation After Prolonged Share Price Weakness](https://longbridge.com/en/news/286895616.md)